Qrativ Company

Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.

Founded Date: 2017-01-01
Technology: ['BioTech & HealthTech']
Funding Status: Early Stage Venture
Total Funding: 8300000.0
Employee Number: 11-50
Headquarters: Cambridge, Massachusetts, United States
Last Funding Date: 2017-07-14
Investors Number: 3.0
Last Funding Type: Series A
Estimated Revenue: $1M to $10M
Industry: Medical BioTech